Ambuja Cements Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Ambuja Cements wird ein jährliches Gewinn- und Umsatzwachstum von 27.3% bzw. 16.7% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 24.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 9.2% betragen.

Wichtige Informationen

27.3%

Wachstumsrate der Gewinne

24.2%

EPS-Wachstumsrate

Basic Materials Gewinnwachstum16.9%
Wachstumsrate der Einnahmen16.7%
Zukünftige Eigenkapitalrendite9.2%
Analystenabdeckung

Good

Zuletzt aktualisiert13 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

We Think That There Are Issues Underlying Ambuja Cements' (NSE:AMBUJACEM) Earnings

Nov 08
We Think That There Are Issues Underlying Ambuja Cements' (NSE:AMBUJACEM) Earnings

Calculating The Fair Value Of Ambuja Cements Limited (NSE:AMBUJACEM)

Oct 31
Calculating The Fair Value Of Ambuja Cements Limited (NSE:AMBUJACEM)

Some Shareholders Feeling Restless Over Ambuja Cements Limited's (NSE:AMBUJACEM) P/E Ratio

Oct 11
Some Shareholders Feeling Restless Over Ambuja Cements Limited's (NSE:AMBUJACEM) P/E Ratio

Ambuja Cements (NSE:AMBUJACEM) May Have Issues Allocating Its Capital

Sep 14
Ambuja Cements (NSE:AMBUJACEM) May Have Issues Allocating Its Capital

Here's Why Ambuja Cements (NSE:AMBUJACEM) Can Manage Its Debt Responsibly

Jul 23
Here's Why Ambuja Cements (NSE:AMBUJACEM) Can Manage Its Debt Responsibly

Returns On Capital At Ambuja Cements (NSE:AMBUJACEM) Have Stalled

May 30
Returns On Capital At Ambuja Cements (NSE:AMBUJACEM) Have Stalled

Ambuja Cements' (NSE:AMBUJACEM) Promising Earnings May Rest On Soft Foundations

May 09
Ambuja Cements' (NSE:AMBUJACEM) Promising Earnings May Rest On Soft Foundations

There's Reason For Concern Over Ambuja Cements Limited's (NSE:AMBUJACEM) Price

Apr 22
There's Reason For Concern Over Ambuja Cements Limited's (NSE:AMBUJACEM) Price

Ambuja Cements (NSE:AMBUJACEM) Hasn't Managed To Accelerate Its Returns

Feb 01
Ambuja Cements (NSE:AMBUJACEM) Hasn't Managed To Accelerate Its Returns

Is Ambuja Cements (NSE:AMBUJACEM) A Risky Investment?

Dec 21
Is Ambuja Cements (NSE:AMBUJACEM) A Risky Investment?

Ambuja Cements (NSE:AMBUJACEM) Could Be Struggling To Allocate Capital

Oct 18
Ambuja Cements (NSE:AMBUJACEM) Could Be Struggling To Allocate Capital

Is Ambuja Cements (NSE:AMBUJACEM) A Risky Investment?

Sep 22
Is Ambuja Cements (NSE:AMBUJACEM) A Risky Investment?

Returns On Capital At Ambuja Cements (NSE:AMBUJACEM) Paint A Concerning Picture

Jul 09
Returns On Capital At Ambuja Cements (NSE:AMBUJACEM) Paint A Concerning Picture

Is Ambuja Cements (NSE:AMBUJACEM) Using Too Much Debt?

Jun 18
Is Ambuja Cements (NSE:AMBUJACEM) Using Too Much Debt?

Ambuja Cements (NSE:AMBUJACEM) Will Want To Turn Around Its Return Trends

Mar 26
Ambuja Cements (NSE:AMBUJACEM) Will Want To Turn Around Its Return Trends

Is Ambuja Cements (NSE:AMBUJACEM) Using Too Much Debt?

Mar 08
Is Ambuja Cements (NSE:AMBUJACEM) Using Too Much Debt?

Weak Statutory Earnings May Not Tell The Whole Story For Ambuja Cements (NSE:AMBUJACEM)

Feb 15
Weak Statutory Earnings May Not Tell The Whole Story For Ambuja Cements (NSE:AMBUJACEM)

Gewinn- und Umsatzwachstumsprognosen

NSEI:AMBUJACEM - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (INR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
3/31/2027496,19957,84234,16090,03522
3/31/2026436,95347,7473,43881,08428
3/31/2025364,96234,296-99,85856,81728
9/30/2024328,50429,740-59,00715,205N/A
6/30/2024327,58233,175N/AN/AN/A
3/31/2024331,59635,76811,63456,458N/A
12/31/2023322,31631,666N/AN/AN/A
9/30/2023320,09627,779-11,83426,037N/A
6/30/2023317,17020,781N/AN/AN/A
3/31/2023310,37019,245-27,9755,879N/A
12/31/2022309,82819,385-53,902-8,362N/A
9/30/2022307,01417,947N/AN/AN/A
6/30/2022302,05323,6736,76237,393N/A
3/31/2022291,50724,920N/AN/AN/A
12/31/2021289,65527,80429,75153,092N/A
9/30/2021287,93132,220N/AN/AN/A
6/30/2021283,15431,78027,03747,608N/A
3/31/2021259,81327,584N/AN/AN/A
12/31/2020245,16223,65430,98748,323N/A
9/30/2020241,84822,247N/AN/AN/A
6/30/2020240,92619,88036,90153,654N/A
3/31/2020265,22521,538N/AN/AN/A
12/31/2019271,03620,95030,71347,387N/A
9/30/2019267,05824,778N/AN/AN/A
6/30/2019266,45823,80418,21330,722N/A
3/31/2019264,12122,830N/AN/AN/A
12/31/2018260,40921,7745,95417,034N/A
9/30/2018254,51816,121N/AN/AN/A
6/30/2018248,20015,850N/AN/AN/A
3/31/2018243,47816,147N/AN/AN/A
12/31/2017235,85515,164N/A34,162N/A
9/30/2017224,32413,481N/AN/AN/A
6/30/2017215,14712,769N/AN/AN/A
3/31/2017206,20712,409N/AN/AN/A
12/31/2016201,31911,051N/A28,103N/A
9/30/2016177,44210,265N/AN/AN/A
12/31/201594,3308,079N/A15,566N/A
12/31/201499,60614,865N/A16,755N/A
12/31/201391,33912,786N/A12,675N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: AMBUJACEMDas prognostizierte Gewinnwachstum (27.3% pro Jahr) liegt über der Sparquote (6.7%).

Ertrag vs. Markt: AMBUJACEMDie Erträge des Unternehmens (27.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (17.9% pro Jahr).

Hohe Wachstumserträge: AMBUJACEMEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: AMBUJACEMDie Einnahmen des Unternehmens (16.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (10.4% pro Jahr).

Hohe Wachstumseinnahmen: AMBUJACEMDie Einnahmen des Unternehmens (16.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: AMBUJACEMDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9.2%).


Wachstumsunternehmen entdecken